Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience.
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience / Francini E; Fiaschi Ai; Petrioli R; Laera L; Bianco V; Ponchietti R; Roviello G.. - In: ANTI-CANCER DRUGS. - ISSN 0959-4973. - STAMPA. - 26:(2015), pp. 884-887. [10.1097/CAD0000000000000257]
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience
Francini E;Laera L;Ponchietti R;Roviello G.
2015
Abstract
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Tolerability-of-cabazitaxel-2015.pdf
Accesso chiuso
Dimensione
101.23 kB
Formato
Adobe PDF
|
101.23 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.